IN.TO - InMed Pharmaceuticals Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/29/2019
6/29/2018
6/29/2017
6/29/2016
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
7,343
5,639
1,927
746
379
Selling General and Administrative
7,254
7,881
6,565
3,630
1,911
Total Operating Expenses
14,734
13,644
8,610
4,474
2,377
Operating Income or Loss
-14,734
-13,644
-8,610
-4,474
-2,377
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
33
-45
0
0
0
Income Before Tax
-14,301
-13,255
-8,521
-4,474
-2,377
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-14,301
-13,255
-8,521
-4,474
-2,377
Net Income
-14,301
-13,255
-8,521
-4,474
-2,377
Net Income available to common shareholders
-14,301
-13,255
-8,521
-4,474
-2,377
Reported EPS
Basic
-
-0.08
-0.06
-0.05
-0.04
Diluted
-
-0.08
-0.06
-0.05
-0.04
Weighted average shares outstanding
Basic
-
171,339
142,452
96,795
60,197
Diluted
-
171,339
142,452
96,795
60,197
EBITDA
-
-13,520
-8,492
-4,376
-2,290